disopyramide has been researched along with bisaramil in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Haruno, A; Hashimoto, K | 1 |
Haruno, A; Hashimoto, K; Sugiyama, A | 1 |
3 other study(ies) available for disopyramide and bisaramil
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bridged Bicyclo Compounds, Heterocyclic; Chlorobenzenes; Digitalis Glycosides; Disease Models, Animal; Disopyramide; Dogs; Epinephrine; Female; Flecainide; Injections, Intra-Arterial; Lidocaine; Male; Ouabain; Verapamil | 1995 |
Chronotropic, inotropic, dromotropic and coronary vasodilator effects of bisaramil, a new class I antiarrhythmic drug, assessed using canine isolated, blood-perfused heart preparations.
Topics: Animals; Anti-Arrhythmia Agents; Atrioventricular Node; Blood Flow Velocity; Bridged Bicyclo Compounds, Heterocyclic; Chlorobenzenes; Coronary Vessels; Disopyramide; Dogs; Female; Flecainide; Heart; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Reperfusion; Sinoatrial Node; Vasodilation | 1999 |